Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01966003
Title Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Subjects With Advanced Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Amgen
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab

Bevacizumab-awwb

Carboplatin + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.